The application period for "Asahi Kasei Pharma Open Innovation" has started. Applications can be submitted until 8:00 GMT on February 28, 2023.
Asahi Kasei Pharma is publicly calling for new proposals related to drug discovery research as part of its efforts for open innovation, to promote pharmaceutical research and development through enhanced cooperation with universities, research institutes, and enterprises around the world.
The application period begins at 5:00 a.m. GMT on January 5, 2023, and ends at 8:00 a.m. GMT on February 28, 2023.
Proposals are solicited concerning new drug seeds (drug target and drug candidate) and technologies in the therapeutic fields of autoimmune disease, renal disease, neurodegenerative disease and bone disease, and drug discovery platform technology.
Submissions will be assessed for their potential for collaborative research. Further information is available on Asahi Kasei Pharma’s Open Innovation website:
https://www.asahikasei-pharma.co.jp/a-compass/en/
and in the following pdf-document:
https://www.asahikasei-pharma.co.jp/a-compass/en/dl/ASAHIKASEIPHARMA_OPENINNOVATION_en.pdf